🔥🐔 BizChicken 🐔🔥

Companies Similar to Apyx Medical Corporation

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

AEON Biopharma, Inc.

AEON Biopharma, Inc. logo
Market Cap: Lowest
Employees: Lowest

ABP-450

AEON Biopharma, Inc. is a biopharmaceutical company focused on developing botulinum toxins for treating debilitating medical conditions. The company also develops ABP-450 for migraines, cervical dystonia, and gastroparesis.

Tags: ABP-450, biopharmaceutical, botulinum toxins, cervical dystonia, gastroparesis, medical conditions, migraines

Symbol: AEON

Recent Price: $0.56

Industry: Biotechnology

CEO: Mr. Marc Forth

Sector: Healthcare

Employees: 5

Address: 4040 Macarthur Boulevard, Newport Beach, CA 92614

Phone: 949-354-6499

Last updated: 2024-12-31

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. logo
Market Cap: Highest
Employees: Highest

EYLEA, Dupixent, Libtayo, Praluent, REGEN-COV, Kevzara, Inmazeb

Regeneron Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes medicines for treating various diseases worldwide, including treatments like EYLEA, Dupixent, Libtayo, and more.

Tags: biotechnology, diseases, healthcare, injections, medicines, pharmaceuticals, treatment

Symbol: REGN

Recent Price: $702.59

Industry: Biotechnology

CEO: Dr. Leonard S. Schleifer M.D., Ph.D.

Sector: Healthcare

Employees: 14165

Address: 777 Old Saw Mill River Road, Tarrytown, NY 10591-6707

Phone: 914 847 7000

Leadership

  • Leonard S. Schleifer, MD, PhD, Board co-Chair, President and Chief Executive Officer
  • George D. Yancopoulos, MD, PhD, Board co-Chair, President and Chief Scientific Officer
  • Zoran Berkovic, Senior Vice President, Financial Planning and Analysis
  • Maya Bermingham, Senior Vice President, Public Policy and Government Affairs
  • Leonard Brooks, Senior Vice President, Treasurer
  • John Calabro, Senior Vice President, Internal Audit
  • Christina Chan, Senior Vice President, Corporate Affairs
  • Larry Coury, PhD, Senior Vice President, Associate General Counsel
  • Ryan Crowe, Senior Vice President, Investor Relations & Strategic Analysis
  • Matthew Everett, Senior Vice President, Global Procurement
  • Chris Fenimore, Senior Vice President, Finance and Chief Financial Officer
  • Rick Hall, Senior Vice President, Human Resources
  • Justin Holko, Senior Vice President, Global Oncology/Hematology Commercial Business Unit
  • Nouhad Husseini, Senior Vice President, Business Development
  • Joseph J. LaRosa, Executive Vice President, General Counsel and Secretary
  • Melissa Lozner, Senior Vice President, Chief Compliance Officer
  • Marion McCourt, Executive Vice President, Commercial
  • Bob McCowan, Senior Vice President, IT and Chief Information Officer
  • Gonzalo Merino, PhD, Senior Vice President, Chief Intellectual Property Counsel and Associate General Counsel
  • Richard O’Neal, Senior Vice President, Market Access
  • Sally A. Paull, Executive Vice President, Human Resources
  • Smita Pillai, Senior Vice President, Culture and DEI and Chief DEI Officer
  • George Poth, Senior Vice President, Real Estate & Facilities Management
  • Alessandra Ravetti, Senior Vice President, Associate General Counsel
  • Kerry Reinertsen, PhD, Senior Vice President, Strategic Alliances
  • David Snow, Senior Vice President, Global Head, Dupixent Franchise
  • Mark Volpe, Senior Vice President, Tax
  • Bola Akinlade, MD, FACP, Senior Vice President, Clinical Development, Immunology and Inflammation
  • Hanne Bak, PhD, Senior Vice President, Preclinical Manufacturing and Process Development
  • Aris Baras, MD, Senior Vice President, Regeneron Genetics Center®
  • Ned Braunstein, MD, Executive Vice President, Regulatory Affairs and Global Patient Safety
  • Gang Chen, PhD, Senior Vice President, Protein Expression Sciences
  • Thomas DiCioccio, PhD, Senior Vice President, Pharmacometrics
  • Benjamin Drosman, Senior Vice President, Global Development Quality & Regulatory Compliance
  • Gregory Geba, MD, PhD, Senior Vice President, Global Development Scientific Council
  • Philip Gregory, DPhil, Senior Vice President, Regeneron Cell Medicines
  • Gary Herman, MD, Senior Vice President, Early Clinical Development and Experimental Sciences
  • Boaz Hirshberg, MD, Senior Vice President, Clinical Sciences General Medicine
  • Diana Hughes, MBBS, Senior Vice President, Global Patient Safety
  • Bari Kowal, Senior Vice President, Development Operations and Portfolio Management
  • Christos Kyratsous, PhD, Senior Vice President, Research
  • Johnathan Lancaster, MD, PhD, Senior Vice President, Global Medical Affairs
  • John Lin, MD, PhD, Senior Vice President, Immuno-Oncology and Head of Bispecifics
  • Israel Lowy, MD, PhD, Senior Vice President, Translational and Clinical Sciences, Oncology
  • Lynn Macdonald, PhD, Senior Vice President, Research
  • Lori Morton, PhD, Senior Vice President, Research
  • Andrew Murphy, PhD, Executive Vice President, Research
  • Muriel O'Byrne, PhD, Senior Vice President, International Regulatory Affairs & Head, European Business Office
  • William Olson, PhD, Senior Vice President, Therapeutic Proteins
  • Mohammed Shameem, PhD, Senior Vice President, Formulations Development
  • L. Andres Sirulnik, MD, PhD, Senior Vice President, Translational and Clinical Sciences, Hematology
  • Randy Soltys, PhD, Senior Vice President, Drug Safety and Pharmacometrics
  • Neil Stahl, PhD, Executive Vice President, Research and Development
  • Robert Vitti, MD, Senior Vice President, Clinical Trial Excellence Strategy
  • Brian Zambrowicz, PhD, Executive Vice President, Functional Genomics and Chief VelociGene® Operations
  • Rajesh Ahuja, Senior Vice President, Fill/Finish and External Manufacturing
  • Frederick Austin, Senior Vice President, Quality Control, Raheen
  • Christine Childrose, Senior Vice President, Human Resources and HR Operations
  • David Crenshaw, Senior Vice President, Associate General Counsel
  • Tikiri Dissanayake, Senior Vice President, IOPS Technical Operations
  • Patrice Gilooly, Senior Vice President, Quality Assurance and Operations
  • Jennifer McNay, PhD, Senior Vice President, CMC Regulatory Sciences and Industrial Affairs
  • Niall O’Leary, Senior Vice President and Site Head, IOPS Raheen
  • Scott Oberman, Senior Vice President, Supply Chain Operations
  • David Simon, Senior Vice President, IOPS Finance and Business Operations
  • Daniel Van Plew, Executive Vice President and General Manager, Industrial Operations and Product Supply
  • Benjamin Yocum, Senior Vice President, Manufacturing Operations
  • James Wolfe, Senior Vice President, Process Sciences and Drug Product Engineering
  • Bonnie L. Bassler, PhD, Director
  • Michael S. Brown, MD, Director
  • N. Anthony Coles, MD, Chair of the Board
  • Joseph L. Goldstein, MD, Director
  • Kathryn Guarini, PhD, Director
  • Christine A. Poon, Lead Independent Director
  • Arthur F. Ryan, Director
  • Huda Y. Zoghbi, MD, Director
  • Samantha Dickon, Director, Development Program Management
  • Gervasio Batista, Sr. Scientist, Neuroscience
  • James K. Gibson, Senior Regional Director, Immunology/Pulmonary
  • Beth Brause, Director, Field Reimbursement Management
  • Eric Prendergast, Director, Pricing Strategy
  • Ashley Neff, Manager, Digital Communications
  • Shari Loock, Associate Director, Sourcing
  • Jennifer Davidson Hamilton, VP and Head of Precision Medicine
  • Yi Zhang, Director, Health Economics & Outcomes Research
  • Wilson Caldwell III, Director, GCO Vendor & Relationship Management
  • David Stein, Director, Medical Operations
  • Regeneron, Corporate
  • Grant Anicete, Biotech Production Specialist I / IOPS Rensselaer
  • Mary McKenna, Lead Quality Control Analyst / IOPS Raheen
  • Ashley Lebby, Lead Senior Biotech Production Specialist / IOPS Rensselaer
  • Varenka Rodriguez Diblasi, Principal Scientist, Bioinformatics
  • Jessie Brown, Manager, Integrative Translational Genetics
  • Gisu Eom, Lead Cloud DevOps Engineer
  • Carmen Kenworthy, Scientist, Velocigene
  • Ralph Hazlewood, Sr. Manager, Research Program Management
  • Brandy Bennett, Sr. Director, R&D Strategy & Operations

Last updated: 2024-12-31

Pyxis Oncology, Inc.

Pyxis Oncology, Inc. logo
Market Cap: Low
Employees: Lowest

PYX-106, PYX-102, PYX-201, PYX-202, PYX-203

Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, focuses on developing therapies to treat various cancers through immune-oncology and antibody drug conjugate product candidates.

Tags: antibody drug conjugate, biopharmaceutical, cancer therapy, immune-oncology, solid tumors

Symbol: PYXS

Recent Price: $1.56

Industry: Biotechnology

CEO: Dr. Lara S. Sullivan M.D., MBA

Sector: Healthcare

Employees: 55

Address: 35 Cambridgepark Drive, Cambridge, MA 02140

Phone: 617 221 9059

Last updated: 2024-12-31

Reneo Pharmaceuticals, Inc.

Reneo Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

REN001

Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on developing therapies for patients with rare genetic mitochondrial diseases. Its primary product, REN001, is a selective peroxisome proliferator-activated receptor delta agonist currently in clinical trials.

Tags: Clinical Trials, Genetic Disorders, Mitochondrial Diseases, Pharmaceuticals, Therapeutics

Symbol: RPHM

Recent Price: $18.20

Industry: Biotechnology

CEO: Mr. Gregory J. Flesher

Sector: Healthcare

Employees: 8

Address: 18575 Jamboree Road, Irvine, CA 92612

Phone: 619 733 3852

Last updated: 2024-12-31

Vaccinex, Inc.

Vaccinex, Inc. logo
Market Cap: Lowest
Employees: Lowest

pepinemab

Vaccinex, Inc., a clinical-stage biotechnology company, focuses on developing targeted biotherapeutics for cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate, pepinemab, is in clinical trials for multiple serious conditions.

Tags: autoimmune disorders, biotechnology, biotherapeutics, cancer, clinical trials, neurodegenerative diseases

Symbol: VCNX

Recent Price: $1.11

Industry: Biotechnology

CEO: Dr. Maurice Zauderer Ph.D.

Sector: Healthcare

Employees: 37

Address: 1895 Mount Hope Avenue, Rochester, NY 14620

Phone: 585 271 2700

Last updated: 2024-12-31

Aethlon Medical, Inc.

Aethlon Medical, Inc. logo
Market Cap: Lowest
Employees: Lowest

Aethlon Hemopurifier

Aethlon Medical, Inc. is a medical technology company focused on developing diagnostic and therapeutic products for life and organ threatening diseases, including the Aethlon Hemopurifier device for removing tumor-derived exosomes and viruses.

Tags: COVID-19, cancer, diagnostic, exosomes, immunotherapeutic device, medical technology, therapeutic, viruses

Symbol: AEMD

Recent Price: $0.66

Industry: Medical - Devices

CEO: Mr. James B. Frakes M.B.A.

Sector: Healthcare

Employees: 14

Address: 11555 Sorrento Valley Road, San Diego, CA 92121

Phone: 619 941 0360

Leadership

  • James B. Frakes, Chief Executive Officer and Chief Financial Officer
  • Steven LaRosa, M.D., Chief Medical Officer
  • John Nguyen, Vice President of Manufacturing
  • Edward G. Broenniman, Chairman of the Board
  • Angela Rossetti,
  • Chetan S. Shah, M.D.,
  • Nicolas Gikakis, Director

Last updated: 2024-12-31

Agenus Inc.

Agenus Inc. logo
Market Cap: Low
Employees: Medium

Retrocyte Display

Agenus Inc. is a clinical-stage immuno-oncology company that discovers and develops immuno-oncology products, offering antibody expression platforms, vaccine programs, and various monoclonal antibodies for cancer treatment.

Tags: antibody expression, cancer treatment, clinical trials, immuno-oncology, vaccine development

Symbol: AGEN

Recent Price: $2.69

Industry: Biotechnology

CEO: Dr. Garo H. Armen Ph.D.

Sector: Healthcare

Employees: 389

Address: 3 Forbes Road, Lexington, MA 02421-7305

Phone: 781 674 4400

Last updated: 2024-12-31

Apyx Medical Corporation

Apyx Medical Corporation logo
Market Cap: Lowest
Employees: Low

Renuvion, J-Plasma

Apyx Medical Corporation is an energy technology company that develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. It operates in two segments: Advanced Energy and Original Equipment Manufacturing (OEM).

Tags: OEM, cosmetic surgery, energy solutions, medical devices, surgical technology

Symbol: APYX

Recent Price: $1.58

Industry: Medical - Devices

CEO: Mr. Charles D. Goodwin II

Sector: Healthcare

Employees: 252

Address: 5115 Ulmerton Road, Clearwater, FL 33760

Phone: 727 384 2323

Last updated: 2024-12-31

Aura Biosciences, Inc.

Aura Biosciences, Inc. logo
Market Cap: Medium
Employees: Low

AU-011

Aura Biosciences, Inc. operates as a biotechnology company developing virus-like drug conjugates (VDC) platform for treating ocular and urologic oncology tumors, with a focus on AU-011 for choroidal melanoma.

Tags: VDC technology, biotechnology, cancer therapy, choroidal melanoma, ocular oncology, oncology

Symbol: AURA

Recent Price: $8.13

Industry: Biotechnology

CEO: Dr. Elisabet de los Pinos Ph.D.

Sector: Healthcare

Employees: 88

Address: 85 Bolton Street, Cambridge, MA 02140

Phone: 617 500 8864

Leadership

  • David Johnson, Chairman
  • Elisabet de los Pinos, PhD, Chief Executive Officer
  • Giovanni Mariggi, PhD, Director
  • Antony Mattessich, Director
  • Sapna Srivastava, PhD, Director
  • Karan Takhar, Director

Last updated: 2024-12-31

Celularity Inc.

Celularity Inc. logo
Market Cap: Lowest
Employees: Low

CYCART-19, CYNK-001, CYNK-101, APPL-001, PDA-002

Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and Bio Banking.

Tags: biotechnology, cancer, cell therapies, immune diseases, infectious diseases, placental-derived

Symbol: CELU

Recent Price: $2.05

Industry: Biotechnology

CEO: Dr. Robert Joseph Hariri M.D., Ph.D.

Sector: Healthcare

Employees: 120

Address: 170 Park Avenue, Florham Park, NJ 07932

Phone: 908 768 2170

Leadership

  • Robert J. Hariri, M.D., Ph.D., Chairperson, Founder, and CEO
  • David Beers, CFA, Chief Financial Officer
  • Stephen Brigido, DPM, President, Degenerative Diseases
  • John Haines, Global Manager and Chief Administrative Officer
  • K. Harold Fletcher, Esq., General Counsel & Chief Compliance Officer
  • John Colerangle, DVM, Ph.D., Regulatory Affairs
  • Anna Gosiewska, Ph.D., R&D, Degenerative Diseases
  • Sharmila Koppisetti, M.D., Clinical Development Immunology & Drug Safety
  • Carmine Palummo, Corporate Operations
  • Tim Wilk, Technical Operations
  • Robert J. Hariri, M.D., Ph.D, Chairperson, Founder & CEO
  • Peter Diamandis, M.D., Director
  • Dean Kehler, Director
  • Geoffrey Shiu Fei Ling, M.D., Ph.D., Director
  • Diane Parks, Director

Last updated: 2024-12-31

EyePoint Pharmaceuticals, Inc.

EyePoint Pharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Low

ILUVIEN, YUTIQ, DEXYCU, EYP-1901, YUTIQ50

Eye Point Pharmaceuticals, Inc. develops and commercializes ophthalmic products for treating eye diseases, including innovative treatments like ILUVIEN, YUTIQ, and DEXYCU. Their efforts serve the United States, China, and the United Kingdom, focusing on diseases such as diabetic macular edema and chronic non-infectious uveitis.

Tags: DEXYCU, ILUVIEN, YUTIQ, biotechnology, eye diseases, eye health, micro-insert, ophthalmic, ophthalmology, pharmaceutical, treatment, vision

Symbol: EYPT

Recent Price: $7.02

Industry: Biotechnology

CEO: Dr. Jay S. Duker M.D.

Sector: Healthcare

Employees: 121

Address: 480 Pleasant Street, Watertown, MA 02472

Phone: 617 926 5000

Last updated: 2024-12-31

Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated logo
Market Cap: High
Employees: Lowest

Kyprolis, Evomela, Veklury, Teriparatide, Vaxneuvance, Pneumosil, Rylaze, Nexterone, Zulresso, Noxafil-IV

Ligand Pharmaceuticals Incorporated is a biopharmaceutical company focused on developing or acquiring technologies to aid pharmaceutical companies in discovering and developing medicines. The company's commercial programs include treatments for multiple myeloma, COVID-19, osteoporosis, invasive diseases, childhood pneumonia, and acute lymphoblastic leukemia.

Tags: biopharmaceutical, commercial programs, disease treatment, medicine development, pharmaceutical technology

Symbol: LGND

Recent Price: $105.76

Industry: Biotechnology

CEO: Mr. Todd C. Davis Ph.D.

Sector: Healthcare

Employees: 58

Address: 5980 Horton Street, EmeryVille, CA 94608

Phone: 858 550 7500

Last updated: 2024-12-31

Nexalin Technology, Inc.

Nexalin Technology, Inc. logo
Market Cap: Lowest
Employees: Lowest

Nexalin Device

Nexalin Technology, Inc., a medical device company, develops neurostimulation products for treating mental health disorders. It markets the Nexalin Device, a therapy for anxiety and insomnia, and is developing Generation 2 for treating substance abuse and other conditions.

Tags: anxiety, clinical trials, insomnia, medical device, mental health, neurostimulation, substance abuse

Symbol: NXL

Recent Price: $2.82

Industry: Medical - Devices

CEO: Mr. Mark White

Sector: Healthcare

Employees: 6

Address: 1776 Yorktown, Houston, TX 77056

Phone: 713 660 1100

Last updated: 2024-12-31

AVITA Medical, Inc.

AVITA Medical, Inc. logo
Market Cap: Low
Employees: Low

RECELL System

AVITA Medical Inc. is a commercial-stage regenerative tissue company providing regenerative products for unmet medical needs in burn injuries, trauma injuries, chronic wounds, dermatological and aesthetics conditions. Their key product, RECELL System, aids in treating acute thermal burns using the patient's own skin cells.

Tags: RECELL System, burn injuries, medical devices, regenerative medicine, skin regeneration

Symbol: RCEL

Recent Price: $13.21

Industry: Medical - Devices

CEO: Mr. James M. Corbett

Sector: Healthcare

Employees: 207

Address: 28159 Avenue Stanford, Valencia, CA 91355

Phone: 661 367 9170

Last updated: 2024-12-31

Revance Therapeutics, Inc.

Revance Therapeutics, Inc. logo
Market Cap: Medium
Employees: Medium

Daxibotulinumtoxin A

Revance Therapeutics, Inc. is a biotechnology company focused on developing, manufacturing, and commercializing neuromodulators for various aesthetic and therapeutic indications.

Tags: aesthetic, biotechnology, clinical trials, neuromodulators, therapeutic

Symbol: RVNC

Recent Price: $3.06

Industry: Biotechnology

CEO: Mr. Mark J. Foley

Sector: Healthcare

Employees: 597

Address: 1222 Demonbreun Street, Nashville, TN 37203

Phone: 615 724 7755

Leadership

  • Mark J. Foley, Chief Executive Officer
  • Tobin Schilke, Chief Financial Officer
  • Erica Jordan, Chief Commercial Officer
  • Dwight O. Moxie, Chief Legal Officer and General Counsel
  • Amie Krause, Chief People Officer
  • David A. Hollander, Chief Medical Officer, Global Therapeutics Franchise Lead
  • Angus C. Russell, CHAIRMAN OF THE BOARD, CHAIR, NOMINATING AND GOVERNANCE COMMITTEE
  • Chris Nolet, Chair, Audit Committee
  • Jill Beraud, CHAIR, BRAND COMMITTEE, COMPENSATION COMMITTEE
  • Vlad Coric,
  • Julian S. Gangolli,
  • Carey O’Connor Kolaja,
  • Olivia C. Ware,

Last updated: 2024-12-31

Rezolute, Inc.

Rezolute, Inc. logo
Market Cap: Low
Employees: Lowest

RZ358

Rezolute, Inc. is a clinical stage biopharmaceutical company focused on developing transformative therapies for metabolic diseases related to chronic glucose imbalance. Its lead product, RZ358, is aimed at treating congenital hyperinsulinism.

Tags: biopharmaceutical, clinical stage, congenital hyperinsulinism, genetic disorder, glucose imbalance, metabolic diseases

Symbol: RZLT

Recent Price: $4.89

Industry: Biotechnology

CEO: Mr. Nevan Charles Elam J.D.

Sector: Healthcare

Employees: 59

Address: 201 Redwood Shores Parkway, Redwood City, CA 94065

Phone: 650 206 4507

Last updated: 2024-12-31

AbbVie Inc.

AbbVie Inc. logo
Market Cap: Highest
Employees: Highest

HUMIRA, SKYRIZI, RINVOQ, IMBRUVICA, VENCLEXTA, MAVYRET, CREON, Synthroid, Linzess/Constella, Lupron

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide, offering a range of therapies including HUMIRA for autoimmune diseases and MAVYRET for HCV infection.

Tags: autoimmune diseases, biotechnology, gastroenterology, healthcare, oncology, pharmaceuticals

Symbol: ABBV

Recent Price: $176.20

Industry: Drug Manufacturers - General

CEO: Mr. Robert A. Michael

Sector: Healthcare

Employees: 50000

Address: 1 North Waukegan Road, North Chicago, IL 60064-6400

Phone: 847 932 7900

Last updated: 2024-12-31

Avanos Medical, Inc.

Avanos Medical, Inc. logo
Market Cap: Medium
Employees: High

Mic-Key, Corpak, Neo Med, Ballard, Microcuff, Endoclear, On-Q, amb IT, Game Ready, Coolief

Avanos Medical, Inc. is a medical technology company focused on delivering medical device solutions globally. They offer chronic care products in digestive and respiratory health, and non-opioid pain solutions.

Tags: chronic care, digestive health, medical technology, non-opioid pain solutions, respiratory health

Symbol: AVNS

Recent Price: $15.58

Industry: Medical - Devices

CEO: Mr. Michael C. Greiner

Sector: Healthcare

Employees: 3771

Address: 5405 Windward Parkway, Alpharetta, GA 30004

Phone: 844 428 2667

Last updated: 2024-12-31

Axcelis Technologies, Inc.

Axcelis Technologies, Inc. logo
Market Cap: High
Employees: High

Ion implantation and semiconductor processing equipment

Axcelis Technologies designs, manufactures, and services ion implantation and processing equipment for semiconductor chip fabrication, offering high energy, high current, and medium current implanters worldwide.

Tags: High Current, High Energy Implanters, Ion Implantation, Manufacturing, Medium Current, Semiconductor, Semiconductor Equipment

Symbol: ACLS

Recent Price: $70.02

Industry: Semiconductors

CEO: Dr. Russell J. Low Ph.D.

Sector: Technology

Employees: 1620

Address: 108 Cherry Hill Drive, Beverly, MA 01915-1053

Phone: 978 787 4000

Leadership

  • Russell Low, PhD, President and Chief Executive Officer
  • James Coogan, Executive Vice President and Chief Financial Officer
  • Gerry Blumenstock, Executive Vice President, Engineering
  • Lynnette C. Fallon, Executive Vice President, Human Resources and Legal, General Counsel
  • Rob Mahoney, Senior Vice President, Global Operations
  • Greg Redinbo, PhD, Executive Vice President, Marketing and Applications
  • Chris Tatnall, PhD, Executive Vice President, Global Customer Operations

Last updated: 2024-12-31

Nuvectis Pharma, Inc.

Nuvectis Pharma, Inc. logo
Market Cap: Low
Employees: Lowest

NXP800, NXP900

Nuvectis Pharma, Inc., is a biopharmaceutical company that focuses on developing precision medicines for treating serious unmet medical needs in oncology. It is working on products like NXP800, a heat shock factor 1 pathway inhibitor, and NXP900, a drug candidate targeting Proto-oncogene c-Src and YES1 kinases.

Tags: NXP800, NXP900, biopharmaceutical, oncology, precision medicine

Symbol: NVCT

Recent Price: $5.14

Industry: Biotechnology

CEO: Mr. Ron Bentsur M.B.A.

Sector: Healthcare

Employees: 13

Address: 1 Bridge Plaza, Fort Lee, NJ 07024

Phone: 201 614 3150

Last updated: 2024-12-31